P
ProKidney Corp. (PROK)
NCM – Real vaqt narxi. Valyuta: USD
1.83
+0.13 (7.65%)
Yopilishda: Jun 26, 2026, 4:00 PM EDT
1.82
-0.01 (-0.55%)
Bozordan keyin: Jun 26, 2026, 7:21 PM EDT
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
Find any stock by ticker or company name
NCM – Real vaqt narxi. Valyuta: USD
1.83
+0.13 (7.65%)
Yopilishda: Jun 26, 2026, 4:00 PM EDT
1.82
-0.01 (-0.55%)
Bozordan keyin: Jun 26, 2026, 7:21 PM EDT
ProKidney Corp., klinik bosqichdagi biotexnologiya kompaniyasi, Qo'shma Shtatlarda surunkali buyrak kasalliklarini davolash uchun hujayra terapiyalarini ishlab chiqish bilan shug'ullanadi. Kompaniya surunkali buyrak kasalliklari va 2-tip diabetni davolash uchun III bosqich klinik sinovlarida bo'lgan avtologik tanlangan buyrak hujayralaridan iborat hujayra terapiyasi bo'lgan rilparencelni ishlab chiqadi. Shuningdek, u rilparencelning kriokonservalangan versiyalarini ishlab chiqishda ishtirok etadi, shu jumladan REGEN-006 va REGEN-008, ikkalasi ham III bosqich klinik sinovlarida; REGEN-002, REGEN-003 va REGEN-007, II bosqich klinik sinovlarida; va REGEN-004, I bosqich klinik sinovlarida. Kompaniya 2015 yilda tashkil etilgan va shtab-kvartirasi Shimoliy Karolina shtatining Uinston-Salem shahrida joylashgan.
| Ism | Lavozim |
|---|---|
| Dr. Bruce Culleton M.D. | CEO & Director |
| Dr. Darin J. Weber Ph.D. | Chief Reg. Off, SVP and Head of Global Reg. Affairs, Quality Mgmt, Biometrics & Market Access |
| Dr. Emily Butler Ph.D. | Senior VP of Biometric |
| Dr. Joseph M. Stavas M.D., M.P.H. | SVP of Clinical Affairs |
| Dr. Ulrich Ernst Ph.D. | EVP of Science and Technology |
| Mr. James Coulston CPA | Chief Financial Officer |
| Mr. Kenneth Locke | Chief Technical Officer |
| Mr. Richard Williams | Chief Information Officer |
| Mr. Todd C. Girolamo Esq., J.D., M.B.A. | Chief Legal Officer & Secretary |
| Ms. Carla Poulson | Chief People Officer |
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-05-29 | 8-K | prok-20260528.htm |
| 2026-05-15 | 8-K | prok-20260515.htm |
| 2026-05-15 | 10-Q | prok-20260331.htm |
| 2026-04-17 | DEFA14A | ny20066059x2_defa14a.htm |
| 2026-04-17 | DEF 14A | ny20066059x1_def14a.htm |
| 2026-04-17 | ARS | ny20066059x3_ars.pdf |
| 2026-03-18 | S-8 | prok-20260318.htm |
| 2026-03-18 | 10-K | prok-20251231.htm |
| 2026-02-02 | 8-K | prok-20260202.htm |
| 2026-01-12 | 8-K | prok-20260112.htm |